A recent New York Times article asked if a genetic mutation could be the key to wiping out heart disease. Dutch professor John Kastelein, PhD, MD, said it could be the final nail in the coffin of heart disease. But John LaMattina, PhD, former president of Pfizer Global Research, says everybody needs to take a deep breath.

Methamphetamine abuse significantly increases one’s morbidity leading to complications such as arrhythmias, hypertension and methamphetamine-associated cardiomyopathy (MACM).

Scientists from China have developed a new paper strip test that could allow heart failure patients to monitor their condition at home.

Implantable cardioverter defibrillators (ICDs) have been proven effective in reducing mortality in patients with severe systolic heart failure. A recent study used two models—one for heart failure and another for proportional risk—to identify patients less likely to benefit from ICDs.

In a new study led by researchers at Geisinger Obesity Institute in Danville, Pennsylvania, investigators were surprised when they saw overwhelming evidence that weight-loss surgery decreased long-term risks of heart failure by more than half in obese patients.

New research presented at the American Thoracic Society conference in San Francisco has provided evidence that people with chronic obstructive pulmonary disease (COPD) or have a history or risk for cardiovascular disease more often suffer from heart attack and stroke.

Researchers from Linkoping University in Sweden have developed a tablet device that can help treat heart failure patients, reports DNA.

The American Heart Association (AHA) announced May 17 the launch of four research projects all focused on examining heart disease in women.